Peptide receptor radionuclide therapy (PRRT) has been shown to be safe and effective for patients with grade 3 (G3) neuroendocrine neoplasms (NENs), according to research presented at the Society of Nuclear Medicine and Molecular Imaging's (SNMMI) 66th Annual Meeting.
A new chemoradiotherapy formulation could kill head and neck cancer cells more effectively -- without the side effects.
A collaborative team of scientists led by Baylor College of Medicine has assembled the largest study to date to evaluate cancer risk in children with birth defects.
University of Arizona researchers have identified a network of neurons that coordinate with other brain regions to influence eating behaviors. These findings could help those suffering from disease-induced appetite loss or over-eating.
Colorado study sequences 33 canine cancer cell lines to identify 'human' genetic changes could be driving these canine cancers, possibly helping veterinary oncologists use more human medicines to cure cancer in dogs.
A novel therapy using two targeted treatments for prostate cancer has been shown to maximize efficacy while reducing side effects according to research presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2019 Annual Meeting.
A new systemic review of the literature has shown a clear gap in the understanding of cancer in lesbian, gay, bisexual, transgender and/or intersex (LGBTI) adolescents and young adults (AYA).
Researchers develop molecular testing to distinguish patients who may need less from those who may need more therapy for HER2 positive breast cancer.
To better understand the cells that brain tumors recruit, scientists developed advanced imaging techniques to visualize macrophages.
A team of researchers from Jena presents a groundbreaking new method for the rapid, gentle and reliable detection of tumors with laser light. The Leibniz Institute of Photonic Technology (Leibniz IPHT) introduced a compact device for rapid cancer diagnosis during surgery at the leading trade fair "Laser World of Photonics" from 24 to 27 June 2019 in Munich. The optical method will help surgeons to remove tumors more precisely and perspectively could make cancer operations possible without a scalpel.